Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (579)	2/18/1999 1:25:00 PM
From: LLCF	Read Replies (3) \| Respond to of 1073

<Slightly OT> If anyone cares 1500 CEPH May 10 calls traded today on a pretty high volatility... I'm hearing Morgan Stanley sold and the "crowd" (MM's) bought. This is positive because it means Morgan has a client willing to take down 150K at this price. DAK

To: Jim Oravetz who wrote (579)	2/18/1999 2:18:00 PM
From: nigel bates	Respond to of 1073

Jim, any idea how this compares with Caliper's efforts ? nig

To: Jim Oravetz who wrote (579)	2/25/1999 7:51:00 AM
From: Jim Oravetz	Respond to of 1073

Bonus 2:1 Rewiring the brain How a bright idea became an innovative medical device BY WILLIAM J. HOLSTEIN In the late 1980s, Alim-Louis Benabid, an Algerian-born neurosurgeon in Grenoble, France, was searching for new ways to control the crippling effects of Parkinson's disease. He hit on the idea of expanding the role of brain-stimulating electrodes, which were used during surgery to determine which part of the brain should be operated on to minimize tremors. Why not create a way to permanently stimulate the right spot, without destroying the brain? he wondered..... usnews.com Under the "Also on the Web" check out the informative: The CDER Handbook The Center for Drug Evaluation and Research, part of the U.S. Food and Drug Administration, has an online handbook that details the process of drug development, review, and approval. fda.gov